Award
NIH Reporter #11238533
Regulation and tumorigenesis of non-classical RAS oncoproteins - Resubmission
Recipient
Not specified
Award Amount
$543,820.00
Ceiling
$543,820.00
Awarded
December 22, 2025
Identifier
11238533
This award funds research on non-classical RAS oncoproteins to develop targeted cancer therapies using biochemical, structural, and pharmacological methods.
Description
The project focuses on the regulation and tumorigenesis of non-classical RAS oncoproteins, specifically RIT1 and MRAS. The work involves biochemical, structural, and pharmacological approaches. The project aims to develop mechanism-based and precise medicines for targeting oncogenic pathways in cancer.